Accustem Sciences Inc. (ACUT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in USD.

Revenue Quarterly

0 35K 70K 105K Q2 '26: 98.4K Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-600K -400K -200K 0 200K 400K 600K Q3 '24: -328.2K Q4 '24: -372.1K Q1 '25: -440.4K Q2 '25: -401.4K Q3 '25: -399.9K Q4 '25: -514.4K Q1 '26: -485.9K Q2 '26: -252.6K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-600K -400K -200K 0 200K 400K 600K Q3 '24: -328.2K Q4 '24: -372.1K Q1 '25: -440.4K Q2 '25: -401.4K Q3 '25: -399.9K Q4 '25: -514.4K Q1 '26: -485.9K Q2 '26: -252.6K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q3 '24: -217.9K Q4 '24: 414 Q1 '25: -290.2K Q2 '25: 21.6K Q3 '25: -604.1K Q4 '25: 22.4K Q1 '26: -374.2K Q2 '26: -248.8K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q1 '22: 363.8K Q2 '22: -1M Q3 '22: -555.3K Q4 '22: -622.3K Q1 '22 Q2 '22 Q3 '22 Q4 '22

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6M 12M 18M Q1 '24: 11.3M Q2 '24: 11.3M Q3 '24: 11.3M Q1 '25: 12.7M Q2 '25: 16.1M Q3 '25: 16.1M Q1 '26: 16.1M Q2 '26: 16.1M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.15 -0.10 -0.05 0.00 0.05 0.10 0.15 Q3 '24: -0.12 Q4 '24: -0.13 Q1 '25: -0.11 Q2 '25: -0.11 Q3 '25: -0.10 Q4 '25: -0.11 Q1 '26: -0.11 Q2 '26: -0.11 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.